Esophageal Cancer
Copyright ©2006 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Dec 21, 2006; 12(47): 7585-7590
Published online Dec 21, 2006. doi: 10.3748/wjg.v12.i47.7585
Persistent CXCR4 expression after preoperative chemoradiotherapy predicts early recurrence and poor prognosis in esophageal cancer
Kenji Koishi, Reigetsu Yoshikawa, Tohru Tsujimura, Tomoko Hashimoto-Tamaoki, Syoudou Kojima, Hidenori Yanagi, Takehira Yamamura, Yoshinori Fujiwara
Kenji Koishi, Reigetsu Yoshikawa, Syoudou Kojima, Hidenori Yanagi, Takehira Yamamura, Yoshinori Fujiwara, Second Department of Surgery, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan
Reigetsu Yoshikawa, Tomoko Hashimoto-Tamaoki, Institute for Advanced Medical Sciences, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan
Tohru Tsujimura, Second Department of Pathology, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan
Tomoko Hashimoto-Tamaoki, Department of Genetics, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan
Author contributions: All authors contributed equally to the work.
Supported by grants from the Medical Research Fund of Hyogo Medical Association
Correspondence to: Reigetsu Yoshikawa, MD, PhD, Second Department of Surgery, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan. yosikr2s@hyo-med.ac.jp
Telephone: +81-798-456372 Fax: +81-798-456373
Received: August 23, 2006
Revised: September 18, 2006
Accepted: September 24, 2006
Published online: December 21, 2006
Core Tip